Patterns of recurrence and metastasis in BRCA1/BRCA2 ‐associated breast cancers

Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors

(2018) M Diossy et al.   ANNALS OF ONCOLOGY

Profiles of Brain Metastases: Prioritization of Therapeutic Targets

(2018) Sherise D. Ferguson et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

(2018) D Ross Camidge et al.   LANCET ONCOLOGY

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

(2018) Jennifer K. Litton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer

(2017) Naama Halpern et al.   INTERNATIONAL JOURNAL OF CANCER

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working Group

(2017) Nancy U. Lin et al.   JOURNAL OF CLINICAL ONCOLOGY

Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations

(2017) S. Balendran et al.   JOURNAL OF NEURO-ONCOLOGY

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

(2017) Mark Robson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations

(2016) R. Lewin et al.   BREAST CANCER RESEARCH AND TREATMENT

Twenty-one-gene recurrence score assay inBRCA-associated versus sporadic breast cancers: Differences based on germline mutation status

(2016) Payal D. Shah et al.   CANCER

Inflammatory breast cancer and development of brain metastases: risk factors and outcomes

(2015) Laura E. G. Warren et al.   BREAST CANCER RESEARCH AND TREATMENT

Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome

(2015) Jennifer M. Matro et al.   Clinical Breast Cancer

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer

(2015) O. Karginova et al.   MOLECULAR CANCER THERAPEUTICS

Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis

(2014) Volker Rudat et al.   BMC CANCER

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers

(2014) Nadine Tung et al.   BREAST CANCER RESEARCH AND TREATMENT

DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer

(2014) Stephan Woditschka et al.   JNCI-Journal of the National Cancer Institute

Effect of Age and Biological Subtype on the Risk and Timing of Brain Metastasis in Breast Cancer Patients

(2014) Man-Hsin Hung et al.   PLoS One

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations

(2013) S. Bayraktar et al.   CLINICAL & EXPERIMENTAL METASTASIS

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

(2012) Nancy U. Lin et al.   CANCER

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

(2012) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers

(2011) Larissa J. Lee et al.   CANCER

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

(2011) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study

(2011) Pamela J. Goodwin et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence of and survival following brain metastases among women with inflammatory breast cancer

(2010) S. Dawood et al.   ANNALS OF ONCOLOGY

Metastatic Behavior of Breast Cancer Subtypes

(2010) Hagen Kennecke et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia

(2009) Mario Budroni et al.   BMC CANCER

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer

(2008) Nancy U. Lin et al.   CANCER

Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer

(2008) Deann P. Atchley et al.   JOURNAL OF CLINICAL ONCOLOGY